Semaglutide is usually well tolerated with related dropout prices when compared with placebo, even though it could be considerably less effectively tolerated than dulaglutide (Trulicity).1,3 The most common adverse consequences are nausea, vomiting, and diarrhea and can be professional by about 30% of sufferers, ordinarily when the dose is greater.